News Links
Press Releases and Product Information April 20, 2022
Introducing a New Standard for Diabetes Care Mylan Pharmaceuticals Inc., a Viatris Company, Conducting Voluntary Nationwide Recall of One Batch of Insulin Glargine (Insulin glargine-yfgn) Injection, 100 units/mL (U-100), Due to the Potential for a Missing Label in the Batch The mysterious case of Viatris and the missing insulin label deepens Dexcom announces availability of G6 for Tricare members as formulary pharmacy benefit Surf’s up: Startup stoked as Chris Garabedian fund funnels cash into ultra-rapid insulin program
Read MorePopular Press News for April 20, 2022
The Kickback Problem and the Cost of Insulin Why the drug pricing debate is focused on insulin New Cases of Childhood Diabetes Rose during the Pandemic The Global Diabetes Compact: a promising first year Management of Diabetes During Ramadan Will insulin bill help diabetics with skyrocketing out of pocket costs?
Read MoreResearch News for April 20, 2022
Smart erythrocyte-hitchhiking insulin delivery system for prolonged automatic blood glucose control Modelling System of Two Insulin-Glucose Delays to Achieve the Dynamics of Glucose Changes (Full text HTML, PDF) Current Topics of Relevance to the Xenotransplantation of Free Pig Islets (Full text HTML, PDF) The Theory of Hyperlipidemic Memory of Type 1 Diabetes (Full text HTML, PDF) The Impact of Intestinal Microorganisms and Their Metabolites on Type 1 Diabetes Mellitus (Full text HTML, PDF) Viral infection-related gene upregulation in monocytes in children with signs of β-cell autoimmunity HLA-DRB1 and -DQB1 Alleles, Haplotypes and Genotypes in Emirati Patients with Type 1 Diabetes […]
Read MoreDaily Care News for April 20, 2022
Glycemic Outcomes During Real-World Hybrid Closed-Loop System Use by Individuals With Type 1 Diabetes in the United States Efficacy and safety of carbohydrate counting versus other forms of dietary advice in patients with type 1 diabetes mellitus: A systematic review and meta-analysis of randomized clinical trials GoFundMe as a Medical Plan: Ecological Study of Crowdfunding Insulin Success Young Children with Type 1 Diabetes: Recent Advances in Behavioral Research The risk for developing vision threatening diabetic retinopathy is influenced by heredity to diabetes A case report of Maturity-onset diabetes of the young 12: large fragment deletion in ABCC8 gene with literature […]
Read MoreLegislative and Policy News for April 13, 2022
The Winners and Losers of the Proposed Insulin Cost Cap
Read MoreCeliac News for April 13, 2022
Celiac Disease May Go Unnoticed For Years Gluten-free year-round: Celebrating Passover with Celiac disease Liver function changes following the introduction of a gluten-free diet in patients with celiac disease (Full text HTML, PDF) Sources of dietary gluten in the first two years of life and associations with celiac disease autoimmunity and celiac disease in Swedish genetically predisposed children: TEDDY study Sex differences in Gluten-free Dietary Adherence and Clinical Symptoms in Patients with Long-term Treated Dermatitis Herpetiformis (Full text HTML)
Read MorePress Releases and Product Information April 13, 2022
Aspect Biosystems and JDRF partner to treat type 1 diabetes Collaboration with SmartStart Health to unlock life-changing benefits of CGM in diabetes Medtronic’s recall of over 175,000 MiniMed pumps labeled Class II by FDA Diabeloop announces integration of insulin automatization software for use with insulin pens Senseonics announces first Eversense E3 CGM implant in U.S.
Read MorePopular Press News for April 13, 2022
Among insulin cap vote, moms of children with diabetes demand action Competitive dancer with Type 1 diabetes is an inspiration to others Doctors report pediatric diabetes cases on the rise Pitching in: Following in her father’s footsteps in battle against type 1 diabetes California Studying First-in-Nation Plan to Make and Sell Low-Cost ‘Cal Rx’ Insulin
Read More